These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 31087357)
1. Convergence of Wnt and Notch signaling controls ovarian cancer cell survival. Bocchicchio S; Tesone M; Irusta G J Cell Physiol; 2019 Dec; 234(12):22130-22143. PubMed ID: 31087357 [TBL] [Abstract][Full Text] [Related]
2. Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance. Nagaraj AB; Joseph P; Kovalenko O; Singh S; Armstrong A; Redline R; Resnick K; Zanotti K; Waggoner S; DiFeo A Oncotarget; 2015 Sep; 6(27):23720-34. PubMed ID: 26125441 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma. Lin HH; Feng WC; Lu LC; Shao YY; Hsu CH; Cheng AL Cancer Lett; 2016 Oct; 381(1):58-66. PubMed ID: 27431312 [TBL] [Abstract][Full Text] [Related]
4. Gamma-Secretase Inhibitor IX (GSI) Impairs Concomitant Activation of Notch and Wnt-Beta-Catenin Pathways in CD44 Barat S; Chen X; Cuong Bui K; Bozko P; Götze J; Christgen M; Krech T; Malek NP; Plentz RR Stem Cells Transl Med; 2017 Mar; 6(3):819-829. PubMed ID: 28186678 [TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA MALAT1 regulates ovarian cancer cell proliferation, migration and apoptosis through Wnt/β-catenin signaling pathway. Guo C; Wang X; Chen LP; Li M; Li M; Hu YH; Ding WH; Wang X Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3703-3712. PubMed ID: 29949143 [TBL] [Abstract][Full Text] [Related]
6. Dual targeting of Notch and Wnt/β-catenin pathways: Potential approach in triple-negative breast cancer treatment. Nasser F; Moussa N; Helmy MW; Haroun M Naunyn Schmiedebergs Arch Pharmacol; 2021 Mar; 394(3):481-490. PubMed ID: 33052427 [TBL] [Abstract][Full Text] [Related]
7. The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner. Wiese M; Walther N; Diederichs C; Schill F; Monecke S; Salinas G; Sturm D; Pfister SM; Dressel R; Johnsen SA; Kramm CM Oncotarget; 2017 Apr; 8(16):27300-27313. PubMed ID: 28460484 [TBL] [Abstract][Full Text] [Related]
8. Potential of platinum-resensitization by Wnt signaling modulators as treatment approach for epithelial ovarian cancer. Kaltofen T; Preinfalk V; Schwertler S; Fraungruber P; Heidegger H; Vilsmaier T; Vattai A; Czogalla B; Mayr D; Mahner S; Jeschke U; Trillsch F J Cancer Res Clin Oncol; 2020 Oct; 146(10):2559-2574. PubMed ID: 32681294 [TBL] [Abstract][Full Text] [Related]
9. Numb/Notch signaling pathway modulation enhances human pancreatic cancer cell radiosensitivity. Bi YL; Min M; Shen W; Liu Y Tumour Biol; 2016 Nov; 37(11):15145-15155. PubMed ID: 27677287 [TBL] [Abstract][Full Text] [Related]
10. Berbamine suppresses cell proliferation and promotes apoptosis in ovarian cancer partially via the inhibition of Wnt/β-catenin signaling. Zhang H; Jiao Y; Shi C; Song X; Chang Y; Ren Y; Shi X Acta Biochim Biophys Sin (Shanghai); 2018 Jun; 50(6):532-539. PubMed ID: 29701777 [TBL] [Abstract][Full Text] [Related]
11. Dexmedetomidine upregulates microRNA-185 to suppress ovarian cancer growth via inhibiting the SOX9/Wnt/β-catenin signaling pathway. Tian H; Hou L; Xiong Y; Cheng Q Cell Cycle; 2021 Apr; 20(8):765-780. PubMed ID: 33818283 [TBL] [Abstract][Full Text] [Related]
12. The role of R-spondin 1 through activating Wnt/β-catenin in the growth, survival and migration of ovarian cancer cells. Liu Q; Zhao Y; Xing H; Li L; Li R; Dai J; Li Q; Fang S Gene; 2019 Mar; 689():124-130. PubMed ID: 30572097 [TBL] [Abstract][Full Text] [Related]
13. Canonical Wnt pathway inhibitor ICG-001 induces cytotoxicity of multiple myeloma cells in Wnt-independent manner. Grigson ER; Ozerova M; Pisklakova A; Liu H; Sullivan DM; Nefedova Y PLoS One; 2015; 10(1):e0117693. PubMed ID: 25635944 [TBL] [Abstract][Full Text] [Related]
14. The CREB-binding protein inhibitor ICG-001 suppresses pancreatic cancer growth. Arensman MD; Telesca D; Lay AR; Kershaw KM; Wu N; Donahue TR; Dawson DW Mol Cancer Ther; 2014 Oct; 13(10):2303-14. PubMed ID: 25082960 [TBL] [Abstract][Full Text] [Related]
15. Label-Free Quantitative Proteomics Combined with Biological Validation Reveals Activation of Wnt/β-Catenin Pathway Contributing to Trastuzumab Resistance in Gastric Cancer. Liu W; Yuan J; Liu Z; Zhang J; Chang J Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29986466 [TBL] [Abstract][Full Text] [Related]
16. TRIP13 promotes proliferation and invasion of epithelial ovarian cancer cells through Notch signaling pathway. Zhou XY; Shu XM Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):522-529. PubMed ID: 30720159 [TBL] [Abstract][Full Text] [Related]
17. Cyclin-Dependent Kinase 14 Promotes Cell Proliferation, Migration and Invasion in Ovarian Cancer by Inhibiting Wnt Signaling Pathway. Ou-Yang J; Huang LH; Sun XX Gynecol Obstet Invest; 2017; 82(3):230-239. PubMed ID: 27505004 [TBL] [Abstract][Full Text] [Related]
18. Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells. Wang R; Sun Q; Wang P; Liu M; Xiong S; Luo J; Huang H; Du Q; Geller DA; Cheng B Oncotarget; 2016 Feb; 7(5):5754-68. PubMed ID: 26735577 [TBL] [Abstract][Full Text] [Related]
19. Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia. Gang EJ; Hsieh YT; Pham J; Zhao Y; Nguyen C; Huantes S; Park E; Naing K; Klemm L; Swaminathan S; Conway EM; Pelus LM; Crispino J; Mullighan CG; McMillan M; Müschen M; Kahn M; Kim YM Oncogene; 2014 Apr; 33(17):2169-78. PubMed ID: 23728349 [TBL] [Abstract][Full Text] [Related]
20. Notch signaling represses hypoxia-inducible factor-1α-induced activation of Wnt/β-catenin signaling in osteoblasts under cobalt-mimicked hypoxia. Li CT; Liu JX; Yu B; Liu R; Dong C; Li SJ Mol Med Rep; 2016 Jul; 14(1):689-96. PubMed ID: 27220406 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]